Blue Willow is a Michigan-based biopharmaceutical company that develops intranasal vaccines for the treatment of respiratory infections and food allergies... Read more
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$38.3M

News

Nov 06, 2025
GlobalNewswire
Press Release: BlueWillow Biologics : BlueWillow Biologics' Intranasal Bird Flu Vaccine Shows Signs of Broad Immune Response in Phase I Clinical Trial Published in Nature Communications
Oct 28, 2024
Benzinga
BlueWillow Biologics: BlueWillow Biologics to Present Significant Progress on Its Novel Intranasal Vaccine Technology at World Vaccine Congress Europe
Mar 02, 2022
BioSpace
BlueWillow Biologics: BlueWillow Biologics and Medigen Vaccine Biologics Announce Positive Results for Intranasal COVID-19 Booster Candidate in Pre-clinical Studies
Jan 26, 2022
PharmaLive
BlueWillow Biologics: BlueWillow's Non-Viral Intranasal Vaccine Enhances Immunity and Broadens Options
Oct 26, 2021
Business Wire
Press Release: BlueWillow Biologics : BlueWillow Biologics to Present During BARDA Industry Day 2021
Sep 22, 2021
Citybizlist
BlueWillow Biologics: BlueWillow Biologics Appoints Robin Isaacs, M.D., Akiko Iwasaki, Ph.D., and Steve Projan, Ph.D to Scientific Advisory Board
Aug 24, 2021
MarketScreener
BlueWillow Biologics: BlueWillow Biologics Announces Positive Interim Results from Phase 1 Trial of Intranasal Anthrax Vaccine
Nov 17, 2020
DBusiness Magazine
BlueWillow Biologics: Ann Arbor's BlueWillow Biologics Working on Nasal COVID-19 Vaccine
Nov 12, 2020
PharmaLeaders
BlueWillow Biologics: Medigen, BlueWillow collaborate to develop SARS-CoV-2 intranasal vaccine
Nov 11, 2020
OINDPnews
BlueWillow Biologics: BlueWillow and Medigen partner on development of intranasal vaccine to prevent COVID-19

BlueWillow Biologics Competitors

1VBI
2Microbiotix, Inc.
3Nanospectra
4Inovio
5Immune Design
6PaxVax
7Kite Pharma
8Genocea
9ChemoCentryx
10Agenus

Trending Companies